Disease/Infection News

RSS

Researchers use Parrondo’s paradox to relieve the cost of COVID-19

The outbreak of coronavirus disease 2019 (COVID-19) has spread rapidly across the globe at an alarming pace, causing considerable anxiety and fear among the general public.

23 Oct 2020

Researchers develop a novel method to test for COVID-19 antibodies

When Dr. Stephen Smith of Seattle Children's Research Institute came down with muscle aches, gastrointestinal distress and a sudden loss of smell in late February, he suspected he had COVID-19.

23 Oct 2020

New report calls for improved Medicare home health benefit for older adults

Older adults have suffered disproportionately from the COVID-19 pandemic, with increased risk of severe illness and death reported across the globe.

23 Oct 2020

Dexamethasone drug may not benefit COVID-19 patients with diabetes or low albumin levels

A new discovery about how the body transports dexamethasone, a drug that can increase the survival chances of patients with severe COVID-19, suggests diabetes and other factors may reduce its potentially lifesaving effectiveness.

23 Oct 2020

Researchers use viral signatures to reveal transmission patterns of SARS-CoV-2

The coronavirus, responsible for the COVID-19 pandemic, has one official name--SARS-CoV-2. But according to virologists, mutations lead to hundreds of genetically-distinct versions of the virus.

23 Oct 2020

Scientists investigate pathogen transmission and awareness of common wildlife-associated zoonoses

In the tropics and subtropics, families and communities frequently rely on bushmeat for food security as well as basic income. So, while the harvest and trade of wildlife are illegal in many locales, the practice is commonplace, and with it comes the potential for transmission of a zoonotic disease among human populations.

23 Oct 2020

Vitamin C and COVID-19: A Review

In a recent review published in Preprints*, Patrick Holford et al. address vitamin C's role as adjunctive therapy for respiratory infection, sepsis, and COVID-19.

23 Oct 2020

Seropositivity to SARS-CoV-2 among asymptomatic blood donors in New York

New York was the hardest-hit U.S. state during the peak of the outbreak in the country. Now, a team of researchers from the New York Blood Center and Serimmune, an immune intelligence company, aimed to determine the prevalence of seropositive people for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, among healthy blood donors.

23 Oct 2020

Biomimetic virus-like particles for safer positive controls in SARS-CoV-2 detection

In an attempt to overcome these issues, a team of researchers from various departments at the University of California San Diego recently proposed using biomimetic virus-like particles (VLPs) as positive controls for assays used in SARS-CoV-2 detection. Their study is published on the preprint server bioRxiv.

23 Oct 2020

Study raises new questions about viral load in asymptomatic children with COVID-19

New questions are at the forefront as a study published in the Journal of Clinical Microbiology from nine children's hospitals finds that most asymptomatic children who tested positive for COVID-19 had relatively low levels of the virus compared to symptomatic children.

22 Oct 2020

Meaning in life and self-control protect against stress during COVID-19 pandemic

Numerous studies over the last few weeks have pointed out that the effects of the Corona pandemic on people's mental health can be enormous and affect large parts of the population.

22 Oct 2020

Navy researchers evaluate commercial UV sources for viral disinfection to combat COVID-19

U.S. Naval Research Laboratory researchers evaluated commercial ultraviolet (UV) sources for viral disinfection to combat COVID-19 on land and at sea, and established a dedicated UV characterization lab in five days to ensure safe introduction and effective operation of UV sources across the Fleet.

22 Oct 2020

Nutritional status may impact susceptibility to COVID-19, study says

Now, a team of researchers at the London School of Hygiene & Tropical Medicine and the University of Oxford wanted to provide a systematic review of the latest evidence on how malnutrition across all forms, including undernutrition, obesity, and micronutrient status, may influence the susceptibility and severity of COVID-19.

22 Oct 2020

Anxiety and stress caused by COVID-19 associated with body image issues

A new study has found that anxiety and stress directly linked to COVID-19 could be causing a number of body image issues amongst women and men.

22 Oct 2020

Initial lockdown in France substantially curbed COVID-19, but many remain susceptible to the virus

Now, a new study by researchers at the Santé Publique France conducted seroprevalence estimates in France, one of the countries with high COVID-19 cases in Europe.

22 Oct 2020

WHO and Wikimedia Foundation expand public's access to most reliable information about COVID-19

The World Health Organization and the Wikimedia Foundation, the nonprofit that administers Wikipedia, announced today a collaboration to expand the public's access to the latest and most reliable information about COVID-19.

22 Oct 2020

DNA vaccine-induced antibodies neutralize SARS-CoV-2

The coronavirus disease (COVID-19) is far from over as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to ravage across the globe. With the vast spread of the virus, many countries who reported flattening the curve over the past months have reported clusters of new cases and second waves of the outbreak.

22 Oct 2020

$2 million NCI SeroNet grant aims to increase diversity in COVID-19 immunology research

A new, $2 million grant from the NCI Serological Sciences Network for COVID-19 (SeroNet) is aimed at enhancing representation of Black and Hispanic people in SARS-CoV-2 immunology research through the use of storytelling--an approach in which community members become "video stars" and provide honest messages about the importance of being represented in COVID-19 research studies.

22 Oct 2020

First antiviral treatment for COVID-19 receives FDA approval

Today, the U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization.

22 Oct 2020

Recovered COVID-19 patients exhibit cognitive deficits

Researchers in the UK and the United States have reported concerning findings showing that patients who had recovered from coronavirus disease 2019 (COVID-19) exhibited significant cognitive deficits.

22 Oct 2020

Disease/Infection News

Researchers use Parrondo’s paradox to relieve the cost of COVID-19

Researchers develop a novel method to test for COVID-19 antibodies

New report calls for improved Medicare home health benefit for older adults

Dexamethasone drug may not benefit COVID-19 patients with diabetes or low albumin levels

Researchers use viral signatures to reveal transmission patterns of SARS-CoV-2

Scientists investigate pathogen transmission and awareness of common wildlife-associated zoonoses

Vitamin C and COVID-19: A Review

Seropositivity to SARS-CoV-2 among asymptomatic blood donors in New York

Biomimetic virus-like particles for safer positive controls in SARS-CoV-2 detection

Study raises new questions about viral load in asymptomatic children with COVID-19

Meaning in life and self-control protect against stress during COVID-19 pandemic

Navy researchers evaluate commercial UV sources for viral disinfection to combat COVID-19

Nutritional status may impact susceptibility to COVID-19, study says

Anxiety and stress caused by COVID-19 associated with body image issues

Initial lockdown in France substantially curbed COVID-19, but many remain susceptible to the virus

WHO and Wikimedia Foundation expand public's access to most reliable information about COVID-19

DNA vaccine-induced antibodies neutralize SARS-CoV-2

$2 million NCI SeroNet grant aims to increase diversity in COVID-19 immunology research

First antiviral treatment for COVID-19 receives FDA approval

Recovered COVID-19 patients exhibit cognitive deficits

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News